Path of Control, Ki'seichuu (3.5e Monk Fighting Style)

Ki'seichuu

"A rose by any other name would smell as sweet."

Ki'seichuu is a monk fighting style in which the manipulation of ki is the main aspect. Monks trained in this style recognize that ki is just magic energy with a different name. They manipulate ki through metamagic feats in order to increase the effectiveness of ki.

1st-Level Skill Bonus: Spellcraft.

1st-Level Feat: Empower Spell. All damage dealt as ki strikes by a monk are multiplied by 1-1/2.

2nd-Level Feat: Reach Spell. Ki can be shot out of the monk's fists to a maximum range of 30 ft. Treat this as a ranged version of your normal unarmed strike.

6th-Level Feat: Widen Spell. Does not stack with Reach Spell. See Bonus Ability.

6th-Level Bonus Ability: Juujitsushita. A monk who has completed his Ki'seichuu training can now produce a 60 ft x 10 ft ki beam from his hand as a full-round action. You make a single attack roll for all hits by Juujitsushita. The Juujitsushita beam does damage equal to an empowered version of your highest unarmed attack bonus (flurry of blows, unarmed damage dice, etc are included) to all creatures in the path of the beam (Reflex DC 15 + Wis modifier halves).

For example, a 10th level unarmed monk would roll a single die for the attack roll of Juujitsushita. Including flurry of blows and unarmed damage dice, Juujitsushita would look similar to this: 7 + Str Modifier ranged [(3d10 + Str modifier) x 1-1/2].

You must wait one minute before using Juujitsushita again. Juujitsushita can be used up to 1 + Wis or Con modifier (whichever's higher) times per day.

Prerequisites: Knowledge(arcana) 8 ranks, Spellcraft 4 ranks, Ki strike.

Back to Main Page → 3.5e Homebrew → Character Options → Monk Fighting Styles

gollark: * slightly tweaked spike proteins, but the Moderna/Pfizer-BioNTech ones use that too

gollark: Presumably it is, because Novavax's vaccine uses actual spike proteins + adjuvant.

gollark: I thought so, but it turns out that in some age groups it is actually seemingly a net negative to be vaccinated with some of the vaccines, and the non-adenovirus ones don't seem to have this problem so there's a fairly usable solution.

gollark: Younger people apparently experience more blood clots and aren't that at-risk from COVID-19.

gollark: There's a lot of age variance in vaccine deaths *and* blood clots, though.

This article is issued from Dandwiki. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.